632 related articles for article (PubMed ID: 15773587)
1. [Is the primary antiphospholipid syndrome a forerunner of SLE?].
Tarr T; Muzes G; Pitlik E; Lakos G; Csépány T; Soltész P; Zeher M; Szegedi G; Kiss E
Orv Hetil; 2005 Jan; 146(5):203-7. PubMed ID: 15773587
[TBL] [Abstract][Full Text] [Related]
2. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
[TBL] [Abstract][Full Text] [Related]
3. [Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature].
Blanco Y; Ramos-Casals M; García-Carrasco M; Cervera R; Font J; Ingelmo M
Rev Clin Esp; 1999 Sep; 199(9):586-8. PubMed ID: 10568151
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
5. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
7. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
Sarzi-Puttini P; Atzeni F; Carrabba M
Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
[TBL] [Abstract][Full Text] [Related]
8. [Systemic lupus erythematosus and antiphospholipid syndrome].
Gröne HJ
Verh Dtsch Ges Pathol; 1996; 80():21-37. PubMed ID: 9065004
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
Avcin T; Silverman ED
Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
[TBL] [Abstract][Full Text] [Related]
10. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
12. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
[TBL] [Abstract][Full Text] [Related]
13. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
[TBL] [Abstract][Full Text] [Related]
14. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
Shoenfeld Y; Meroni PL; Toubi E
Curr Opin Rheumatol; 2009 Sep; 21(5):495-500. PubMed ID: 19593144
[TBL] [Abstract][Full Text] [Related]
16. [Antiphospholipid syndrome--the description of two cases].
Podrazilová L; Peterová V; Olejárová M; Seidl Z; Dostál C
Vnitr Lek; 2006 Jan; 52(1):89-94. PubMed ID: 16526206
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
18. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
19. Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE?
Al Attia HM
Int J Dermatol; 2006 Apr; 45(4):366-9. PubMed ID: 16650159
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients.
Lefèvre G; Lambert M; Bacri JL; Dubucquoi S; Quemeneur T; Caron C; Launay D; Houfflin-Debarge V; Hachulla E; Kyndt X; Subtil D; Hatron PY
Lupus; 2011 Jul; 20(8):861-5. PubMed ID: 21546412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]